Cases 61 - 70 of 128
Bayer Intellectual Property GMBH et al v. Sunshine Lake Pharma Co., Ltd. et al
as 1:2019cv01448
Defendant:
HEC Pharm USA Inc. and Sunshine Lake Pharma Co., Ltd.
Plaintiff:
Bayer Intellectual Property GMBH, Bayer AG and Janssen Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271
MITSUBISHI TANABE PHARMA CORPORATION et al v. MSN LABORATORIES PRIVATE LTD. et al
as 3:2019cv15616
Plaintiff:
JANSSEN RESEARCH AND DEVELOPMENT, LLC, JANSSEN PHARMACEUTICA NV, MITSUBISHI TANABE PHARMA CORPORATION and others
Defendant:
MSN LABORATORIES PRIVATE LTD. and MSN PHARMACEUTICALS INC.
Cause Of Action: 15 U.S.C. § 1126
Alkermes Pharma Ireland Limited et al v. Luye Pharma Group Ltd. et al
as 1:2019cv01340
Plaintiff:
Alkermes Pharma Ireland Limited, Alkermes Controlled Therapeutics, Inc. and Janssen Pharmaceuticals, Inc.
Defendant:
Luye Pharma (USA) Ltd., Luye Pharma Group Ltd., Nanjing Luye Pharmaceutical Co., Ltd. and others
Cause Of Action: 35 U.S.C. § 271
Bayer Intellectual Property GMBH et al v. Accord Healthcare, Inc. et al
as 1:2019cv01238
Plaintiff:
Bayer Intellectual Property GMBH, Bayer AG and Janssen Pharmaceuticals, Inc.
Defendant:
Intas Pharmaceuticals Limited, Accord Healthcare, Inc. and Accord Healthcare Limited
Cause Of Action: 35 U.S.C. § 271
Bayer Intellectual Property GMBH et al v. Macleods Pharmaceuticals Ltd. et al
as 1:2019cv00880
Defendant:
Macleods Pharmaceuticals Ltd. and Macleods Pharma USA, Inc.
Plaintiff:
Bayer Intellectual Property GMBH, Bayer AG and Janssen Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271
MITSUBISHI TANABE PHARMA CORPORATION et al v. LUPIN LIMITED et al
as 3:2019cv07165
Plaintiff:
JANSSEN RESEARCH AND DEVELOPMENT, LLC, JANSSEN PHARMACEUTICA NV, MITSUBISHI TANABE PHARMA CORPORATION and others
Defendant:
LUPIN LIMITED and LUPIN PHARMACEUTICALS, INC.
Cause Of Action: 28 U.S.C. § 1338
Bayer Intellectual Property GMBH et al v. Teva Pharmaceuticals USA, Inc. et al
as 1:2018cv01926
Defendant:
Teva Pharmaceuticals USA, Inc. and Teva Pharmaceutical Industries Ltd.
Plaintiff:
Bayer Intellectual Property GMBH, Bayer AG and Janssen Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271
MITSUBISHI TANABE PHARMA CORPORATION et al v. PRINSTON PHARMACEUTICAL INC.
as 3:2018cv06112
Plaintiff:
MITSUBISHI TANABE PHARMA CORPORATION , JANSSEN PHARMACEUTICALS, INC. , JANSSEN PHARMACEUTICA NV and others
Defendant:
PRINSTON PHARMACEUTICAL INC.
Counter_claimant:
PRINSTON PHARMACEUTICAL INC.
Counter_defendant:
CILAG GMBH INTERNATIONAL , JANSSEN PHARMACEUTICA NV , JANSSEN PHARMACEUTICALS, INC. and others
Cause Of Action: 15 U.S.C. § 1126
JANSSEN PHARMACEUTICALS, INC. et al v. TEVA PHARMACEUTICALS USA, INC. et al
as 2:2018cv00734
Plaintiff:
JANSSEN PHARMACEUTICALS, INC. and JANSSEN PHARMACEUTICA NV
Defendant:
TEVA PHARMACEUTICALS USA, INC. and TEVA PHARMACEUTICALS INDUSTRIES, LTD.
Cause Of Action: 35 U.S.C. § 271
MITSUBISHI TANABE PHARMA CORPORATION et al v. LUPIN LIMITED et al
as 3:2018cv00292
Plaintiff:
MITSUBISHI TANABE PHARMA CORPORATION , JANSSEN PHARMACEUTICALS, INC. , JANSSEN PHARMACEUTICA NV and others
Defendant:
LUPIN LIMITED and LUPIN PHARMACEUTICALS, INC.
Cause Of Action: 15 U.S.C. § 1126
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
